Market watch ptgx
Web10 mrt. 2024 · Protagonist Therapeutics (NASDAQ:PTGX) Historical Stock Chart From Mar 2024 to Apr 2024 Protagonist Therapeutics (NASDAQ:PTGX) Historical Stock Chart From Apr 2024 to Apr 2024 Latest PTGX... WebQuand je leur dis que je suis traductrice, les gens me demandent souvent « Donc vous faites quoi exactement ? ». Découvrez, dans le premier article (en…
Market watch ptgx
Did you know?
WebProtagonist Therapeutics, Inc. (PTGX) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 18.45 -0.02 (-0.11%) At close: 04:00PM EDT 18.19 -0.26 ( … Web8 apr. 2024 · PTGX stock traded up $0.45 during trading on Friday, hitting $18.47. 1,830,758 shares of the company's stock traded hands, compared to its average volume of 1,692,474. Protagonist Therapeutics, Inc. has a 52 week low of $6.91 and a 52 week high of $25.76.
WebPTGX - Protagonist Therapeutics Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Web4 apr. 2024 · Item 8.01. Other Events. Underwriting Agreement On April 4, 2024, Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (collectively, …
WebAccording to our current PTGX stock forecast, the value of Protagonist Therapeutics shares will drop by -34.92% and reach $ 11.72 per share by April 11, 2024. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). WebFind the latest Invesco Preferred ETF (PGX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Web13 apr. 2024 · The stock has a market capitalization of $5.23 billion, a price-to-earnings ratio of 9.06, a price-to-earnings-growth ratio of 0.72 and a beta of 1.14. Academy Sports and Outdoors Increases Dividend
WebPRGTX U.S.: Nasdaq T Rowe Price Global Technology Fund Watch list Last Updated: Apr 5, 2024 $ 12.11 -0.23 -1.86% Previous Close $12.34 Advanced Charting 9.75 52 Week … rohm upholsteryWeb17 mrt. 2024 · PTGX’s current price about 22.34% and 49.02% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently … rohm thermal print headWebFind market predictions, PTGX financials and market news. View live Protagonist Therapeutics, Inc chart to track its stock's price action. Find market predictions, PTGX … outback 22801Web5 apr. 2024 · NEWARK, CA / ACCESSWIRE / April 4, 2024 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $20.00 per share. outback 244 ubhWeb5 apr. 2024 · Webull offers kinds of Protagonist Therapeutics Inc stock information, including NASDAQ:PTGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTGX stock news, and many more online research tools to help you make informed decisions. outback 2.4 kw generatorWeb10 mrt. 2024 · Protagonist is a $1.25bn market cap biotech using its peptide-based technology platform to develop a portfolio of assets targeting ... but may initiate a long position in PTGX over the next 72 ... outback 23112WebPTGX's price/sales ratio is 41.57; that's higher than the P/S ratio of 96.09% of US stocks. With a year-over-year growth in debt of -37.59%, PROTAGONIST THERAPEUTICS INC's debt growth rate surpasses merely 7.43% of about US stocks. Stocks that are quantitatively similar to PTGX, based on their financial statements, market capitalization, and ... outback 24073